Bausch Health Cos Total Long Term Liabilities 2010-2024 | BHC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Bausch Health Cos total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.

Bausch Health Cos Total Long Term Liabilities 2010-2024 | BHC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Bausch Health Cos total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.

Related Stocks
Company Name	Market Cap
Teva Pharmaceutical Industries (TEVA)	$19.4B
Dr Reddy's Laboratories (RDY)	$11.2B
BridgeBio Pharma (BBIO)	$6.9B
Supernus Pharmaceuticals (SUPN)	$1.9B
Amphastar Pharmaceuticals (AMPH)	$1.5B
Personalis (PSNL)	$412M
Taysha Gene Therapies (TSHA)	$336M
Assembly Biosciences (ASMB)	$81M
Sol-Gel Technologies (SLGL)	$16M
Evoke Pharma (EVOK)	$8M
Teligent (TLGT)	$0M